Costimulatory Molecule Blockade For The Treatment Of Graft-Versus-Host Disease

Allogeneic hematopoietic stem cell transplantation (HCT) has been widely used to treat both malignant and nonmalignant hematological disorders. Despite remarkable success, one complication that occurs in up to approximately 50% of patients undergoing allogeneic HCT is graft-versus-host disease (GVHD), of which there are two forms. These are acute GVHD, usually developing within 100 days, and chronic GVHD, developing 100 days and beyond after HCT. Both are the result of immune reactions of donor lymphoid cells to cellular targets on host tissues.

Unfortunately, chronic GVHD may last several years and is difficult to treat. The major target organs for GVHD are the skin, gastrointestinal (GI) tract, and liver. Although the incidence and severity of liver GVHD has been reduced with ursodiol prophylaxis, chronic skin and GI GVHD are often refractory to immunosuppressive drugs and can severely impair a patient’s quality of life, and causing serious infections that can be fatal.

Although treatment or prevention of acute GVHD has been remarkably successful with post-grafting immunosuppression regimens and corticosteroids, treatment of chronic GVHD has lagged. This has been partly due to an insufficient development of appropriate animal models that recapitulate the full spectrum of chronic GVHD in patients, allowing for a comprehensive evaluation of therapeutic agents.

Recently, we reported the reproducible establishment of chronic GVHD in an outbred canine model. The transplanted animals developed identical, complex clinical symptoms and histopathological findings in the same target organs as seen in human patients. Thus, canines provided an appropriate animal model with which to test novel therapeutics for the treatment of chronic GVHD.

  The Arsenic In Our Food

One current area of intense therapeutic interest to immunologists is the manner in which cells of the immune system signal one another in response to antigen presentation, expansion and differentiation, or cell senescence and death. These studies are particularly applicable to T cells that carry out a number of important immunological functions, including helper activity to other immune cells, suppressor function, and cytolytic activity. T cells are also critically involved in the pathology of GVHD.

In both theory and practice, our ability to interfere or enhance the receptor-based signaling process in the immune response has led to new biologics and drugs that can activate or suppress the immune system for a variety of diseases including cancer and autoimmune disorders. Development of new therapies should encompass a central goal of transplantation, namely to identify methods that produce unresponsiveness to transplanted tissues without limiting the entire immune response.

Of particular interest are costimulatory molecules that are pairs of receptors and their cognate ligands found on cells of the immune system that are constitutively expressed or induced (upregulated) following cell activation. On T cells, inducible costimulator (ICOS) is upregulated following cell activation including during the development of GVHD. The role of ICOS is to help initiate T cell activation when interacting with antigen presenting cells. In the presence of IL-2, ICOS acts to sustain the immune response. Therefore, it follows that blocking ICOS signaling on T cells, the primary orchestrators of GVHD, might halt and potentially reverse chronic GVHD without debilitating the immune system in general.

With this hypothesis in mind, we employed the canine model of chronic GVHD and used a canine-specific mouse monoclonal antibody (mAb) produced against the extracellular domain of canine ICOS. Preliminary in vitro studies indicated that anti-ICOS mAb blocked ICOS signaling in canine peripheral blood lymphocytes. In our chronic GVHD model, 4 of 5 dogs treated with only three injections of anti-ICOS over a 6-day period halted the progression of GVHD.

  Transflammation: A New Frontier In Regenerative Medicine

Notably, gingival tissues returned normal and skin lesions regressed resulting in a survival period significantly greater than the control group that did not receive anti-ICOS therapy. Because the antibody was of murine origin, the dogs were capable of mounting an immune response against the foreign protein, thus limiting the number of treatments the animals received. In the human condition, an antibody can be made to appear human antigenically, and multiple treatments could easily be administered without limitations due to anti-mAb immune responses. MEDI-570 is a humanized anti-ICOS mAb and is used clinically to treat cancers expressing the ICOS receptor. Clinical studies testing the ability of anti-ICOS to treat chronic GVHD in patients are certainly feasible using MEDI-570.

Figure 1. Landmark: Survival after diagnosis of chronic GVHD. The graph shows the survival of dogs with chronic GVHD following one or two courses of anti-ICOS mAb (dashed line) versus untreated dogs (solid line). Dogs were treated immediately following initial clinical signs of skin or gingival chronic GVHD. Animals were humanely euthanized at a point when chronic GVHD affected their well-being. (Image courtesy of Scott S. Graves, made with data from Graves, S. S., Parker, M. H., Stone, D., Sale, G. E., Pillai, S. P., Johnson, M. M., & Storb, R. (2018). Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation,24(1), 50-54. doi:10.1016/j.bbmt.2017.09.010)

These findings are described in the article entitled Anti-Inducible Costimulator Monoclonal Antibody Treatment of Canine Chronic Graft-versus-Host Disease, recently published in the journal Biology of Blood and Marrow Transplantation. This work was conducted by Scott S. Graves, Maura H. Parker, Diane Stone, George E. Sale, Smitha P. S. Pillai, Melissa M. Johnson, and Rainer Storb from the Fred Hutchinson Cancer Research Center.

Speak Your Mind!


Precious Resource Basins: Facilitating Regional Transboundary Cooperation In The Eastern Nile Basin Beyond The River Flow

Cooperation among countries sharing a water basin is often difficult due to historic rivalries, conflict legacies, and the increased utilization […]

Micro-Oxygenation Reveals How And Why Wine Can Sour From Sulfur

Reductive off odors are a series of sulfury notes (rotten eggs, decaying seaweed, putrefaction or cooked cabbage) eventually developed by […]

Witnessing The Rise Or Fall Of A Species: Introgressive Hybridization Of Dolphins In The Greek Seas (Stenella coeruleoalba And Delphinus delphis)

Under some circumstances, it is possible for members of two different species to mate and produce viable offspring. This phenomenon […]

Biochemistry On The Fly: Exploring The Use Of Drones In Sample Pre-Processing

The role of laboratory testing remains a core pillar for disease management where rapid diagnosis and timely and appropriate intervention […]

The Amygdala And Observational Learning

Survival in the world requires the ability to respond appropriately to the things that happen in our environment. We have […]

Transparency About The Costs Of Incarceration Mitigates Sentencing Attitudes

In a study published in Behavioral Sciences & the Law, researchers at Georgia State University sought to understand whether attention […]

Corrosion Inhibition By Essential Oil Extracts: A Sustainable Method Of Controlling Carbon Steel Degradation

Published by Roland Loto Department of Mechanical Engineering, Covenant University, Ota, Ogun State, Nigeria These findings are described in the […]